Overview of Dr. Gray
Dr. Heidi Gray is an obstetrician/gynecologist in Seattle, WA and is affiliated with multiple hospitals in the area, including UW Medicine/University of Washington Medical Center and Fred Hutch Cancer Center. She received her medical degree from David Geffen School of Medicine at UCLA and has been in practice 20 years. Dr. Gray accepts several types of health insurance, listed below. She is one of 174 doctors at UW Medicine/University of Washington Medical Center and one of 17 doctors at Fred Hutch Cancer Center who specialize in Obstetrics & Gynecology. She has more than 70 publications and over 500 citings.
Office
1959 Ne Pacific St
Seattle, WA 98195Fax+1 206-598-3590
Education & Training
- University of Pennsylvania Health SystemFellowship, Gynecologic Oncology, 2001 - 2004
- University of WashingtonResidency, Obstetrics and Gynecology, 1997 - 2001
- David Geffen School of Medicine at UCLAClass of 1997
Certifications & Licensure
- WA State Medical License 1999 - 2025
- PA State Medical License 2001 - 2004
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Ovarian Cancer Vaccine for Patients in Remission Start of enrollment: 2010 Jul 01
- Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms Start of enrollment: 2012 Sep 12
Publications & Presentations
PubMed
- 10 citationsParticipation of Patients With Limited English Proficiency in Gynecologic Oncology Clinical Trials.Soledad Jorge, Shatreen Masshoor, Heidi J Gray, Elizabeth M Swisher, Kemi M Doll
Journal of the National Comprehensive Cancer Network. 2023-01-01 - 2572 citationsIntratumoral T cells, recurrence, and survival in epithelial ovarian cancer.Lin Zhang, Jose R. Conejo-Garcia, Dionyssios Katsaros, Phyllis A. Gimotty, Marco Massobrio
The New England Journal of Medicine. 2003-01-16 - 65 citationsLapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancerKimberly K. Leslie, Michael W. Sill, Heather A. Lankes, Edgar G. Fischer, Andrew K. Godwin
Gynecologic Oncology. 2012-11-01
Other
- Adjuvant treatment of intermediate-risk endometrial cancerGray HJ, Koh W
http://www.uptodate.com/contents/adjuvant-treatment-of-intermediate-risk-endometrial-cancer
UpToDate, Wolters Kluwer Health - 2012-08-14
Press Mentions
- PARIS® Test Identified Effective Therapy for Patient with Terminal Ovarian CancerSeptember 13th, 2021
- SEngine Precision Medicine Presents Data at 2021 AACR Annual Meeting Demonstrating Clinical Utility and Predictive Value of PARIS® Test in Ovarian CancerApril 13th, 2021
- SGO 2019: Despite Missed Endpoint, JAVELIN Trial PD-L1 Subgroup Analysis RedeemsMarch 19th, 2019
Professional Memberships
- Fellow
Insurance Accepted
- Aetna Choice POS II
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Choice
First Health PPO
Great West PPO
Health Alliance PPO
Health Net Oregon PPOHumana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
ODS Network
Premera BCBS Heritage & Heritage Plus 1
Providence Health System Personal Option
Regence Washington - Preferred Provider Network
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Wellmark Alliance Select - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: